Posts Tagged ‘FDA’
Wearable EEG monitoring start-up Epitel raises $12.5M to market seizure detection system
Epitel raises $12.5M for wearable seizure detection system (MobiHealth News): Epitel, maker of a wearable electroencephalogram (EEG) system for seizure detection, announced Wednesday it had scored $12.5 million in Series A funding. The round was led by Catalyst Health Ventures (CHV) and Genoa Ventures, with participation from Dexcom, OSF Ventures, Wavemaker 360, MedMountain Ventures and…
Read MoreDigital therapeutics pioneer Akili Interactive plans to go public in mid-2022 at a $1B valuation
Palihapitiya-Led SPAC to Merge With Akili in $1 Billion Deal (Bloomberg): Akili Interactive, a startup that has developed a video game to help treat attention-deficit disorders in kids, has agreed to go public through a merger with one of Chamath Palihapitiya’s blank-check companies. The deal, which confirms a Bloomberg News report, values the combined entity…
Read MoreAPA: With digital mental health going mainstream, will/ should psychologists be able to “prescribe” interventions?
Mental health, meet venture capital (APA): Until recently, mental health was a relative blip on the radar of venture capitalists. But over the past few years, and particularly since the onset of the COVID-19 pandemic, private investors have made a dramatic run for this space, pouring $3.1 billion into mental health ventures by the third…
Read MoreCould I be wrong? Exploring cognitive bias, curiosity, intellectual humility, and lifelong learning
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring eight timely scientific and industry news plus a few fun teasers to appreciate our unique human brains. #1. Could I be wrong? Exploring research on cognitive bias, curiosity, intellectual humility, and lifelong learning “None of us thinks that our beliefs and attitudes are incorrect; if we…
Read MoreFDA-approved, Cybin-sponsored clinicial trial to measure ketamine’s impact on the brain via Kernel Flow neuroimaging helmet
Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine (Forbes): The U.S. Food and Drug Administration has approved a clinical trial using a neuroimaging helmet made by Los Angeles-based Kernel to track what happens in the brain when a human takes a psychedelic dose of ketamine.
Read MoreStudy: Fewer than 1% of geriatric patients with cognitive complaints met Aduhelm research trial criteria. What can we expect about its real-world safety?
Biogen’s Aduhelm label far exceeds clinical trial population, study says. That could bring real-world surprises (Fierce Pharma): While the chatter surrounding Biogen’s controversial Alzheimer’s med Aduhelm has largely been centered on a pivotal Medicare reimbursement decision as of late, analysts are pointing to one new study that suggests there may be “room for surprises” when…
Read More